Inho Kim

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Aortic Stenosis

Signaling Pathway

Top Venues

Korean circulation journal

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Inho Kim, Chan Soon Park, Hae-Young Lee
Erratum: Correction of Figures in the Article "Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway". Korean circulation journal 54 (6) (2024)
Inho Kim, Chan Soon Park, Hae-Young Lee
Erratum: Correction of Figures in the Article "Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway". Korean circulation journal (2024)
Inho Kim, Chan Soon Park, Hae-Young Lee
Erratum: Correction of Figures in the Article "Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway". Korean circulation journal 54 (6) (2024)
Chan Soon Park, Inho Kim, Gyu-Chul Oh, Jung-Kyu Han, Han-Mo Yang, Kyung Woo Park, Hyun-Jai Cho, Hyun-Jae Kang, Bon-Kwon Koo, Woo-Young Chung, Seil Oh, Hae-Young Lee
Diagnostic Utility and Pathogenic Role of Circulating MicroRNAs in Vasospastic Angina. Journal of clinical medicine 9 (5) (2020)
Inho Kim, Chan Soon Park, Hae-Young Lee
Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway. Korean circulation journal 49 (7) (2019)